A randomized study of cisplatin versus cisplatin plus vindesine for non-small cell lung carcinoma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (17)
Nonparametric Estimation from Incomplete Observations
1992 • 45,923 citations
Nonparametric Estimation from Incomplete Observations
1958 • 37,219 citations
Regression Models and Life-Tables
1992 • 27,454 citations
A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
1965 • 3,333 citations
WHO Handbook for Reporting Results of Cancer Treatment
1982 • 2,214 citations
Estimation of the probability of an event as a function of several independent variables
1967 • 1,585 citations
Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage Schedules
1981 • 367 citations
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
1989 • 325 citations
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.
1986 • 242 citations
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.
1989 • 128 citations
Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.
1986 • 126 citations
The expanding role of cisplatin in the treatment of non-small-cell lung cancer.
1989 • 106 citations
Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized study
1984 • 84 citations
Cisplatin Dose Intensity in Non-Small Cell Lung Cancer: Phase II Results of a Day 1 and Day 8 High-Dose Regimen
1989 • 70 citations
cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
1978 • 55 citations
Phase II evaluation of vindesine in patients with non-small cell carcinoma of the lung.
1979 • 46 citations
Vindesine: an effective agent in the treatment of non-small cell lung cancer.
1982 • 24 citations
Cited By (0)
No citing papers found in database